Mohr Albert J, Leisewitz Andrew L, Jacobson Linda S, Steiner Jörg M, Ruaux Craig G, Williams David A
Department of Companion Animal Clinical Studies, Faculty of Veterinary Science, University of Pretoria, Onderstepoort, South Africa.
J Vet Intern Med. 2003 Nov-Dec;17(6):791-8. doi: 10.1111/j.1939-1676.2003.tb02516.x.
A randomized, controlled clinical trial investigated the effect of early enteral nutrition (EN) on intestinal permeability, intestinal protein loss, and outcome in parvoviral enteritis. Dogs were randomized into 2 groups: 15 dogs received no food until vomiting had ceased for 12 hours (mean 50 hours after admission; NPO group), and 15 dogs received early EN by nasoesophageal tube from 12 hours after admission (EEN group). All other treatments were identical. Intestinal permeability was assessed by 6-hour urinary lactulose (L) and rhamnose (R) recoveries (%L, %R) and L/R recovery ratios. Intestinal protein loss was quantified by fecal alpha1-proteinase inhibitor concentrations (alpha1-PI). Median time to normalization of demeanor, appetite, vomiting, and diarrhea was 1 day shorter for the EEN group for each variable. Body weight increased insignificantly from admission in the NPO group (day 3: 2.5 +/- 2.8%; day 6: 4.3 +/- 2.3%; mean +/- SE), whereas the EEN group exhibited significant weight gain (day 3: 8.1 +/- 2.7%; day 6: 9.7 +/- 2.1%). Mean urinary %L was increased, %R reduced, and L/R recovery ratios increased compared to reference values throughout the study for both groups. Percent lactulose recovery decreased in the EEN group (admission: 22.6 +/- 8.0%; day 6: 17.9 +/- 2.3%) and increased in the NPO group (admission: 11.0 +/- 2.6%; day 6: 22.5 +/- 4.6%, P = .035). Fecal alpha1-PI was above reference values in both groups and declined progressively. No significant differences occurred for %R, L/R ratios, or alpha1-PI between groups. Thirteen NPO dogs and all EEN dogs survived (P = .48). The EEN group showed earlier clinical improvement and significant weight gain. The significantly decreased %L in the EEN versus NPO group might reflect improved gut barrier function, which could limit bacterial or endotoxin translocation.
一项随机对照临床试验研究了早期肠内营养(EN)对细小病毒性肠炎肠道通透性、肠道蛋白质丢失及预后的影响。将犬随机分为2组:15只犬在呕吐停止12小时之前不给予食物(入院后平均50小时;禁食组),15只犬在入院12小时后通过鼻饲管给予早期肠内营养(早期肠内营养组)。所有其他治疗均相同。通过6小时尿乳果糖(L)和鼠李糖(R)回收率(%L、%R)及L/R回收率评估肠道通透性。通过粪便α1-蛋白酶抑制剂浓度(α1-PI)对肠道蛋白质丢失进行定量。早期肠内营养组在行为、食欲、呕吐和腹泻恢复正常的中位时间上,每个变量均比禁食组短1天。禁食组体重自入院后增加不显著(第3天:2.5±2.8%;第6天:4.3±2.3%;均值±标准误),而早期肠内营养组体重显著增加(第3天:8.1±2.7%;第6天:9.7±2.1%)。在整个研究过程中,两组的平均尿%L均升高,%R降低,L/R回收率升高。早期肠内营养组乳果糖回收率降低(入院时:22.6±8.0%;第6天:17.9±2.3%),禁食组升高(入院时:11.0±2.6%;第6天:22.5±4.6%,P = 0.035)。两组粪便α1-PI均高于参考值且逐渐下降。两组间%R、L/R比值或α1-PI无显著差异。13只禁食犬和所有早期肠内营养组犬存活(P = 0.48)。早期肠内营养组临床改善更早且体重显著增加。与禁食组相比,早期肠内营养组显著降低的%L可能反映了肠道屏障功能改善,这可能限制细菌或内毒素移位。